Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Albany International
AIN
$2.13B
| $3.57M | ﹤0.01% |
40,336
+8,442
| +26% | +$711K |
|
1952
Otter Tail
OTTR
$3.79B
| $3.57M | ﹤0.01% |
49,952
+33,134
| +197% | +$2.14M |
|
1953
AZZ Inc
AZZ
$4.48B
| $3.56M | ﹤0.01% |
64,344
+6,968
| +12% | +$378K |
|
1954
Green Brick Partners
GRBK
$3.09B
| $3.56M | ﹤0.01% |
117,289
+16,810
| +17% | +$441K |
|
1955
Hyatt Hotels
H
$16.2B
| $3.55M | ﹤0.01% |
37,017
-56,484
| -60% | -$4.82M |
|
1956
PUT
Franklin Resources
BEN
$18.3B
| $3.55M | ﹤0.01% |
+105,900
| New | +$3.49M |
|
1957
Encore Capital Group
ECPG
$2.06B
| $3.54M | ﹤0.01% |
57,013
+27,603
| +94% | +$1.55M |
|
1958
CALL
T. Rowe Price
TROW
$24.3B
| $3.54M | ﹤0.01% |
+18,000
| New | +$3.66M |
|
1959
Kodiak Sciences
KOD
$2.49B
| $3.53M | ﹤0.01% |
41,642
+27,018
| +185% | +$2.75M |
|
1960
Idacorp
IDA
$8.32B
| $3.52M | ﹤0.01% |
31,117
+1,832
| +6% | +$195K |
|
1961
Rayonier
RYN
$6.48B
| $3.52M | ﹤0.01% |
96,218
+4,279
| +5% | +$149K |
|
|
AAT
1962
American Assets Trust
AAT
$1.47B
| $3.52M | ﹤0.01% |
93,826
+191
| +0.2% | +$7.18K |
|
1963
CALL
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $3.52M | ﹤0.01% |
30,600
| – | – |
|
|
AXNX
1964
DELISTED
Axonics, Inc. Common Stock
AXNX
| $3.51M | ﹤0.01% |
62,740
+33,297
| +113% | +$2.03M |
|
1965
CALL
Baxter International
BAX
$14.5B
| $3.51M | ﹤0.01% |
+40,900
| New | +$3.29M |
|
1966
Newmark Group
NMRK
$2.72B
| $3.5M | ﹤0.01% |
186,999
+106,916
| +134% | +$1.7M |
|
1967
Repligen
RGEN
$8.3B
| $3.5M | ﹤0.01% |
13,200
-22,974
| -64% | -$6.19M |
|
|
LSXMA
1968
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $3.49M | ﹤0.01% |
93,339
-158,673
| -63% | -$5.85M |
|
1969
Medifast
MED
$108M
| $3.49M | ﹤0.01% |
16,645
+847
| +5% | +$175K |
|
1970
Enpro
NPO
$7.06B
| $3.47M | ﹤0.01% |
31,494
+11,203
| +55% | +$1.12M |
|
1971
Graham Holdings Company
GHC
$5.14B
| $3.46M | ﹤0.01% |
5,500
-390
| -7% | -$230K |
|
|
CVET
1972
DELISTED
Covetrus, Inc. Common Stock
CVET
| $3.46M | ﹤0.01% |
173,330
+65,214
| +60% | +$1.23M |
|
1973
NETSCOUT
NTCT
$2.98B
| $3.46M | ﹤0.01% |
104,621
-3,005
| -3% | -$91.1K |
|
1974
Thor Industries
THO
$4.03B
| $3.46M | ﹤0.01% |
33,300
-26,183
| -44% | -$2.84M |
|
1975
Veeco
VECO
$3.11B
| $3.45M | ﹤0.01% |
121,045
+8,003
| +7% | +$204K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.